par Beex, Louk;Rose, Carsten;Mouridsen, Henning;Jassem, J.;Nooij, Marianne;Estape, J.;Paridaens, R.
;Piccart-Gebhart, Martine
;Gorlia, Thierry;Lardenoije, S.;Baila, L.
Référence European journal of cancer, 42, 18, page (3178-3185)
Publication Publié, 2006-12
;Piccart-Gebhart, Martine
;Gorlia, Thierry;Lardenoije, S.;Baila, L.Référence European journal of cancer, 42, 18, page (3178-3185)
Publication Publié, 2006-12
Article révisé par les pairs
| Titre: |
|
| Auteur: | Beex, Louk; Rose, Carsten; Mouridsen, Henning; Jassem, J.; Nooij, Marianne; Estape, J.; Paridaens, R.; Piccart-Gebhart, Martine; Gorlia, Thierry; Lardenoije, S.; Baila, L. |
| Informations sur la publication: | European journal of cancer, 42, 18, page (3178-3185) |
| Statut de publication: | Publié, 2006-12 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Advanced breast cancer |
| Alternated endocrine therapy | |
| Intermittent endocrine therapy | |
| Medroxyprogesterone acetate | |
| Randomised study | |
| Tamoxifen | |
| MeSH keywords: | Adult |
| Aged | |
| Aged, 80 and over | |
| Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
| Breast Neoplasms -- drug therapy | |
| Disease-Free Survival | |
| Drug Resistance, Neoplasm | |
| Female | |
| Humans | |
| Medroxyprogesterone Acetate -- administration & dosage | |
| Medroxyprogesterone Acetate -- adverse effects | |
| Middle Aged | |
| Tamoxifen -- administration & dosage | |
| Tamoxifen -- adverse effects | |
| Note générale: | Clinical Trial, Phase III |
| Comparative Study | |
| Journal Article | |
| Randomized Controlled Trial | |
| Research Support, N.I.H., Extramural | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0959-8049 |
| info:doi/10.1016/j.ejca.2006.08.020 | |
| info:pii/S0959-8049(06)00765-9 | |
| info:scp/33845224929 | |
| info:pmid/17045796 |



